The medication primarily targets metabolic pathways through GIP and GLP-1 receptors, which are widely expressed in pancreatic tissue, the gastrointestinal tract, adipose tissue, and certain brain regions involved in appetite regulation
A friend in my running group mentioned she had switched to Retatrutide through a research supplier after hitting the same wall
Pharmacokinetics (Coskun et al., Cell Metabolism 2022) Phase 1 PK data established the ~6-day half-life and once-weekly dosing rationale
Try proactively reaching for your bottle of water
Clinical trials have shown that GLP-1RAs reduce the incidence of major adverse cardiovascular events in patients with T2DM [6]
After her many years at Yale, she returned back to Mount Sinai as an Assistant Professor of Medicine and Associate Program Director of the endocrinology fellowship program